By your requests we implemented new style home pages, for your convenience. The new portal should look and feel what many of you called Outlook style or Explorer style: project based folders you create on the left, lists of objects on the top right, and the content on the bottom right.
The older home page interface is temporarily available by clicking this notification message. As soon as we migrate all of the tools to the new interface, we make sure that you like it and it sticks, the older home page will be depreciated and discontinued.
We are aware that just like anything else new, some issues may come up, some problems may appear while using the new system. We are working hard to fix those ! But we wanted you to know that we invite your comments. Please, report ANY problems you see. We know that you, our users play an important and critical role in creating HIVE, we appreciate every step, any recommendation, an inquiry and a desire to make HIVE better.
When you talk, we listen!
Please, use the new Home Pages! Enjoy the new interface!.",,?cmd=oldhome
Dr. Vahan Simonyan has a solid scientific background in varied academic disciplines: MS in Physical Organic Chemistry, Ph.D. in Quantum Physics and Mathematics, post-doctoral training in Nanotechnology and Quantum Statistical Thermodynamics. After 2001, he switched his expertise to biotechnology and biomedical informatics and currently serves at the FDA as a lead scientist of HIVE, R&D Director of Bioinformatics. Vahan is a prolific author of scientific publications in physics, chemistry, quantum chemistry, nanotechnology, biotechnology, population dynamics, and bioinformatics. Additionally, Dr. Simonyan is an adjunct professor at the George Washington University, where he teaches and develops curriculums for biomedical big data informatics and biostatistics research and development courses. His accomplishments in academic and R&D technology carriers have been complemented with the success of technology leadership roles at NCBI and FDA where he established large-scale and complex, science-heavy R&D infrastructures capable of serving worldwide communities for research and regulatory purposes.
In 2013, High-performance Integrated Virtual Environment (HIVE) codebase was donated by Dr. Simonyan to the US government in order to build a platform ready to accept NGS data at the US FDA for regulatory review. Today HIVE has supported regulatory review and research leading to peer-reviewed publications in genetics, genomics, proteomics, data modeling, and bioinformatics.
In 2016, Dr. Simonyan and his colleagues (Raja Mazumder and Jeremy Goecks) have published the first BioCompute paper where they introduced the new concept for bioinformatics harmonization. Today BioCompute is represented by a large international consortium of regulatory and research scientists from academia, industry, technology companies and government organizations.
In 2017, the technology experts Dr. Simonyan (FDA) and Shahram Ebadollahi (IBM) have led a research collaboration between FDA and IBM on testing feasibility of blockchain for healthcare data. The initiative called Healthcare Data Exchange Framework (HDEF) targets the facilitation of healthcare data transactions by creating a incentive framework for patient ownership of their medical data.